Concord Drugs Ltd.
BSE: 538965 | Sector: Health care |
NSE: N.A. | ISIN Code: INE858L01010 |
BSE 00:00 | 24 Jun | 21.25 |
-3.10 (-12.73%) |
OPEN
26.40 |
HIGH
26.40 |
LOW
19.50 |
NSE 05:30 | 01 Jan | Concord Drugs Ltd |
OPEN | 26.40 |
PREVIOUS CLOSE | 24.35 |
VOLUME | 5280 |
52-Week high | 37.40 |
52-Week low | 19.50 |
P/E | 11.68 |
Mkt Cap.(Rs cr) | 19 |
Buy Price | 0.00 |
Buy Qty | 0.00 |
Sell Price | 0.00 |
Sell Qty | 0.00 |
- Financial Overview
- Balance Sheet
- Profit & Loss
- Cash Flow
- Ratios
- Quarterly
- Half Yearly
- Nine Monthly
- Yearly
Filter:
Concord Drugs Ltd. (CONCORDDRUGS) - Nine Monthly Result
Particulars (![]() |
Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 |
Net Sales/Income From Operations | 43.49 | 43.01 | 38.31 | 33.73 | 30.70 |
Other Income | 0.08 | 3.60 | 0.07 | 0.06 | 0.02 |
Total Income | 43.57 | 46.61 | 38.39 | 33.80 | 30.72 |
Total Expenditure | 38.56 | 40.52 | 35.68 | 30.78 | 27.04 |
Operating Profit | 5.01 | 6.09 | 2.71 | 3.02 | 3.69 |
Interest | 1.45 | 1.15 | 1.27 | 1.20 | 1.31 |
Gross Profit | 3.57 | 4.94 | 1.43 | 1.81 | 2.37 |
Depreciation | 1.39 | 1.03 | 1.10 | 1.64 | 1.72 |
PBT | 2.18 | 3.91 | 0.34 | 0.17 | 0.66 |
Tax | 0.62 | 0.47 | 0.09 | 0.15 | 0.20 |
Net Profit/(Loss) | 1.57 | 2.94 | 0.24 | 0.20 | 0.46 |
Minority Interest After NP | - | - | - | - | - |
Net Profit after Minority Interest | - | - | - | - | - |
Exceptional Items | 0.00 | 2.65 | 0.00 | 0.00 | 0.00 |
Profit After Exceptional Items | 1.57 | 0.29 | 0.24 | 0.20 | 0.46 |
Equity Share Capital | 8.74 | 8.74 | 8.74 | 7.86 | 7.86 |
Reserves Excluding Revaluation Reserves | 19.59 | 17.44 | 14.65 | 0.00 | 0.00 |
EPS | |||||
Basic EPS | 1.79 | 3.09 | 0.27 | 0.26 | 0.58 |
Public Share Holding | |||||
No Of Shares (Crores) | 0 | 0 | 0 | 0 | 0 |
Share Holding (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Promoters and Promoter Group Shareholding | |||||
a) Pledged/Encumbered | |||||
- Number of Shares (Crores) | 0 | 0 | 0 | 0 | 0 |
- Per. of Shares (as a % of the total sh. of prom. and promoter group) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
- Per. of Shares (as a % of the total Share Cap. of the company) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
b) Non-encumbered | |||||
- Number of Shares (Crores) | 0 | 0 | 0 | 0 | 0 |
- Per. of shares (as a % of the total sh. of prom. and promoter group) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
- Per. of shares (as a % of the total Share Cap. of the company) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Note : | PBT include deferred tax and fringe benefit tax Net profit figures include extra-ordinary items income/expenditure. |
Quick Links for Concord Drugs:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices